Abstract Library

#3646 Thymic neuroendocrine neoplasms – Data from the Czech Neuroendocrine Tumor Registry 2008 – 2022

Introduction: Thymic neuroendocrine neoplasms are very rare, their incidence is only 3% of all NENs a 5% of thymic tumors. On ENETS 2022 Sarah Fodil—Cherif et alt. presented data of 74 patients with thymic NETs from retrospective French study (1988-2020) and their analysis.

Conference:

Presenting Author:

Authors: Sedlackova E, Barkmanova J, Linke Z, Karpianusova T,

Keywords: thymic neoplasms, neuroendocrine tumor,

#3634 Imaging surveillance in multiple endocrine neoplasia type 1 – 10 years of experience with somatostatin receptor positron emission tomography

Introduction: Guidelines for multiple endocrine neoplasia type 1 (MEN1) recommend intensive imaging surveillance without specifying a superior regimen, including the role of somatostatin receptor imaging (SRI) with positron emission tomography (PET).

Conference:

Presenting Author: Andreassen M

Authors: Said M, Krogh J, Feldt-Rasmussen U, Rasmussen �, Kristensen T,

Keywords: Imaging, Multiple endocrine neoplasia type 1, Neuroendocrine neoplasm, Positron emission tomography, Somatostatin receptor,

#1426 Pseudotumor of Thymus Occuring After Hypercortisolism Recovery: Case Report

Introduction: Cushing syndrome is due to an ectopic secreting adrenocorticotropic hormone (ACTH) in 10 % to 20% of cases. Among them, thymic tumors represent almost half of cases. It has been described that patients sometimes develop benign hyperplasia after hypercortisolism correction.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Baki S, El Mghari G, El Ansari N,

Keywords: thymic tumor, Cushing's syndrome, ectopic secretion,

#1318 MEN1 Associated Thymic Neuroendocrine Tumors in Oulu University Hospital Finland

Introduction: Thymic neuroendocrine tumors (TNET) are rare and account 2-5% of all thymic tumors. TNET can occur either sporadically or as a manifestation of an inherited tumor syndrome such as multiple endocrine neoplasia type 1 (MEN1). The prognosis is severe.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Yliaska I

Authors: Yliaska I, Lesonen T, Ebeling T, Koivikko M, Salmela P,

Keywords: thymic neuroendocrine tumor, thymic carcinoid tumor, MEN1,

#258 Diagnosis and Management of Thymic Neuroendocrine Tumors: A Case Series Review

Introduction: Thymic neuroendocrine tumors (TNET) represent rare types of thymic tumors with an incidence of 0.01/100000 per year. They commonly show rapid disease progression and are rarely curable.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Akay E, El-Khouly F, Khan M, Caplin M, Toumpanakis C,

Keywords: thymic, thymic neuroendocrine tumor, radical thymectomy, chemotherapy, somatostatin analogues, Y-90,